<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05900741964188</udiDi>
    <basicUdiDi>B-05900741964188</basicUdiDi>
    <tradeName>Eye juice CRYSTAL</tradeName>
    <deviceName>Eye juice CRYSTAL</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11324_HU</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:42:02.565Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741964089</udiDi>
    <basicUdiDi>B-05900741964089</basicUdiDi>
    <tradeName>Kropia Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11342_CZ_SK</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:59.613Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741964072</udiDi>
    <basicUdiDi>B-05900741964072</basicUdiDi>
    <tradeName>KOMPIN FREE</tradeName>
    <deviceName>KOMPIN FREE</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11343_CZ_SK</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:58.514Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741964010</udiDi>
    <basicUdiDi>B-05900741964010</basicUdiDi>
    <tradeName>HIDRAMEL®</tradeName>
    <deviceName>HIDRAMEL®</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11345_BG</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:32.891Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963839</udiDi>
    <basicUdiDi>B-05900741963839</basicUdiDi>
    <tradeName>CALIMEL®</tradeName>
    <deviceName>CALIMEL®</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11353_LT</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:29.613Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963693</udiDi>
    <basicUdiDi>B-05900741963693</basicUdiDi>
    <tradeName>EYEAZE® LYTE sodium hyaluronate 0,3% eye drops</tradeName>
    <deviceName>EYEAZE® LYTE sodium hyaluronate 0,3% eye drops</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11376_EN</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:26.177Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963648</udiDi>
    <basicUdiDi>B-05900741963648</basicUdiDi>
    <tradeName>CALIMEL®</tradeName>
    <deviceName>CALIMEL®</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11364_RO</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:05.592Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963631</udiDi>
    <basicUdiDi>B-05900741963631</basicUdiDi>
    <tradeName>HIDRAMEL®</tradeName>
    <deviceName>HIDRAMEL®</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11370_RO</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:41:02.172Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963570</udiDi>
    <basicUdiDi>B-05900741963570</basicUdiDi>
    <tradeName>Vedixin intense ulga i nawilżenie</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11334_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:40:58.836Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963563</udiDi>
    <basicUdiDi>B-05900741963563</basicUdiDi>
    <tradeName>Vedixin zmętnienie</tradeName>
    <deviceName>Vedixin zmętnienie</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11332_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:40:51.872Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963402</udiDi>
    <basicUdiDi>B-05900741963402</basicUdiDi>
    <tradeName>Kropia Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11380_TR</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:40:31.261Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963396</udiDi>
    <basicUdiDi>B-05900741963396</basicUdiDi>
    <tradeName>Regenopia</tradeName>
    <deviceName>Regenopia</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11389_TR</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:40:27.845Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963174</udiDi>
    <basicUdiDi>B-05900741963174</basicUdiDi>
    <tradeName>Xailin® HA 0,3% INTENSE</tradeName>
    <deviceName>Xailin® HA 0,3% INTENSE (free sample)</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11378_NL</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:40:21.015Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741963167</udiDi>
    <basicUdiDi>B-05900741963167</basicUdiDi>
    <tradeName>Xailin® HA 0,3% INTENSE</tradeName>
    <deviceName>Xailin® HA 0,3% INTENSE</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11378_NL</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:39:59.959Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962894</udiDi>
    <basicUdiDi>B-05900741962894</basicUdiDi>
    <tradeName>AQUACLAR 50+</tradeName>
    <deviceName>AQUACLAR 50+</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11301_ES</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:39:45.407Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962726</udiDi>
    <basicUdiDi>B-05900741962726</basicUdiDi>
    <tradeName>i-fresh REPAIR</tradeName>
    <deviceName>i-fresh REPAIR</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11389_PT</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:39:20.553Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962665</udiDi>
    <basicUdiDi>B-05900741962665</basicUdiDi>
    <tradeName>Xailin® INTENSE 0,3% HA</tradeName>
    <deviceName>Xailin® INTENSE 0,3% HA (free sample)</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11351_EN_FR_SR_AR_s</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:39:16.522Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962627</udiDi>
    <basicUdiDi>B-05900741962627</basicUdiDi>
    <tradeName>Xailin® INTENSE 0,3% HA</tradeName>
    <deviceName>Xailin® INTENSE 0,3% HA</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11351_EN_FR_SR_AR</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:39:12.968Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962542</udiDi>
    <basicUdiDi>B-05900741962542</basicUdiDi>
    <tradeName>ZUMA n·oka 0,2 FREE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11395_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:39:09.290Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962535</udiDi>
    <basicUdiDi>B-05900741962535</basicUdiDi>
    <tradeName>ZUMA n·oka 0,1 FREE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11392_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:38:47.133Z</lastUpdated>
  </row>
</eudamedExport>